Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003

Abstract

Background-We examined whether population-level hospitalization rates for heart failure (HF) and subsequent survival have continued to improve since the turn of the century. We also examined trends in the prescribing of evidence-based pharmacological treatment for HF.

Do patients have worse outcomes in heart failure than in cancer? A primary care‐based cohort study with 10‐year follow‐up in Scotland

“…Advances in both the medical and device based treatments, have been associated with improved survival rates in patients with HF in many [17][18][19][20] but not all national registry-based studies. 21 Age-standardized death rates from heart failure have been reported to decrease by 40% in seven European countries between 1987 and 2008.…”

Impact of β-2 Thr164Ile and combined β-adrenergic receptor polymorphisms on prognosis in a cohort of heart failure outpatients

“…Available online June 2, 2010. Published June 11, 2010. Heart failure (HF) is an important cause of mortality and hospitalization in Brazil and worldwide and, despite recent advances in the medical treatment of HF, mortality rates and morbidity due to this entity remain elevated (1)(2)(3)(4). Identification of prognostic factors is an important aspect of HF management that has been the focus of intense clinical and basic research (5,6).…”

Heart Failure Management: Continuing to Fail or Signs of Success?

“…Encouragingly progress continues as new pharmacological therapies further improve the prognosis of patients with HF over and above best current treatment [2]. Yet translating these successes into meaningful gains in population level prognosis has been difficult [3]. A number of factors are responsible.…”

“…At the same time we have witnessed a change in the epidemiology of HF. The aging population coupled with better secondary prevention in those with coronary heart disease have conspired to increase the incidence of HF and the age at which people first develop HF [3]. Despite this there are encouraging reports from across the globe that in developed countries the incidence of HF is falling [3,5], another success.…”

“…The aging population coupled with better secondary prevention in those with coronary heart disease have conspired to increase the incidence of HF and the age at which people first develop HF [3]. Despite this there are encouraging reports from across the globe that in developed countries the incidence of HF is falling [3,5], another success. While we assimilate the information from clinical trials, registries and epidemiological studies to build a contemporary picture of HF, few studies are able to provide a comprehensive overview of HF.…”